Shares of other companies:
May 1, 2024 Inflation Persistence: No Fed Rate Cuts in Sight
April 29, 2024 Tesla, Baidu Join Forces for Self-Driving Tech in China
April 27, 2024 Alphabet and Microsoft’s AI Investments Yield Strong Returns
April 26, 2024 Top 10 High Dividend Yield Stocks
3M Stock: Dividend Likely Cut In Half
May 1, 2024
Amazon Q1 Review: Best Of Big Tech Bunch
April 30, 2024
Tesla: The Thesis Is Stronger Than Ever
April 30, 2024
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
April 12, 2024 Improve Your Financial Status: A How-To Guide
Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
HAE Stock News and Mentions of Haemonetics Corporation Stocktwits
Updated: May 2, 2024 (11:06)
Sector: Healthcare
Welcome to PandaPulse, innovative analytical stock market observer, where the latest news and stocktwits meets in-depth investor relations insights. Dive into our real-time sentiment analysis to gauge the mood of the markets and arm yourself with key information that resonates with both savvy investors and casual traders.
We meticulously analyze the sentiment trend in each article for the last 60 days where Haemonetics Company is mentioned. We assess its relevance and importance to carry out an overall sentiment valuation of Haemonetics Corporation (HAE).
You can view the trend designation for each individual article below. We use this data to compile indicators into one comprehensive sentiment value, which represents the current information agenda about the Haemonetics stocks.
Please wait, while the data is preparing...
General evaluation of the current information agenda's sentiments
Agenda Trend
Analyzed articles
News and Mentions of Haemonetics Corporation (HAE)
May 1, 2024 (15:51) / "Zacks Commentary" (by Zacks Equity Research)
Haemonetics ( HAE ) Banks on Plasma Arm Growth Amid Rising Costs
Haemonetics' (HAE) hospital portfolio is evolving and helping to create new opportunities for growth and diversification.
In Article Trend: Somewhat-Bullish
May 1, 2024 (07:00) / "Investors Business Daily" (by INVESTOR'S BUSINESS DAILY)
Haemonetics Shows Rising Relative Price Performance; Still Shy Of Key Threshold
Haemonetics Shows Rising Relative Price Performance. Still Shy Of Key Threshold Investor's Business Daily ...
In Article Trend: Somewhat-Bullish
April 12, 2024 (14:30) / "PR Newswire" (by MarketsandMarkets)
Apheresis Market Worth $3.9 billion | MarketsandMarkets™
CHICAGO, April 12, 2024 /PRNewswire/ -- Apheresis Market in terms of revenue was estimated to be worth $2.6 billion in 2024 and is poised to reach $3.9 billion by 2029, growing at a CAGR of 8.8% from 2024 to 2029 according to a new report by MarketsandMarkets™.
In Article Trend: Somewhat-Bullish
April 12, 2024 (13:03) / "Zacks Commentary" (by Zacks Equity Research)
Why You Should Add Haemonetics ( HAE ) to Your Portfolio Now
Recovery within the Hospital business and the favorable prospects of the Plasma franchise raise investors' optimism for Haemonetics (HAE).
In Article Trend: Somewhat-Bullish
April 9, 2024 (15:40) / "Zacks Commentary" (by Zacks Equity Research)
HAE vs. ABT: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical - Products sector might want to consider either Haemonetics ( HAE Quick QuoteHAE - ) or Abbott ( ABT Quick QuoteABT - ) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.
In Article Trend: Bullish
April 5, 2024 (13:48) / "Zacks Commentary" (by Zacks Equity Research)
Haemonetics' ( HAE ) New TEG 6s Cartridge Gets FDA Approval
Haemonetics' (HAE) TEG testing gives vital information that can assist doctors with better control of their patients' hemostasis.
In Article Trend: Somewhat-Bullish
April 1, 2024 (12:00) / "PR Newswire" (by Haemonetics Corporation)
Haemonetics Corporation Completes Acquisition of Attune Medical
BOSTON, April 1, 2024 /PRNewswire/ -- Haemonetics Corporation ( NYSE: HAE ) , a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, has completed its previously announced acquisition of privately-held Chicago-based Attune ...
In Article Trend: Somewhat-Bullish
March 29, 2024 (13:30) / "Zacks Commentary" (by Zacks Equity Research)
Haemonetics ( HAE ) Crossed Above the 200-Day Moving Average: What That Means for Investors
Should investors be excited or worried when a stock crosses above the 200-day simple moving average?
In Article Trend: Somewhat-Bullish
March 23, 2024 (09:32) / "Stocknews.com" (by Defense World Staff)
Haemonetics ( NYSE:HAE ) Downgraded by StockNews.com to "Hold"
StockNews.com lowered shares of Haemonetics ( NYSE:HAE - Free Report ) from a buy rating to a hold rating in a report published on Friday. HAE has been the subject of several other reports.
In Article Trend: Somewhat-Bullish
March 11, 2024 (13:30) / "Zacks Commentary" (by Zacks Equity Research)
Haemonetics ( HAE ) Recently Broke Out Above the 50-Day Moving Average
Good things could be on the horizon when a stock surpasses the 50-Day simple moving average. How should investors react?
In Article Trend: Bullish
March 6, 2024 (11:54) / "Zacks Commentary" (by Zacks Equity Research)
Haemonetics ( HAE ) Signs Agreement to Acquire Attune Medical
Haemonetics' (HAE) acquisition of the privately held Attune Medical is likely to add the pioneering ensoETM device to its EP portfolio.
In Article Trend: Somewhat-Bullish
March 5, 2024 (11:00) / "PR Newswire" (by Haemonetics Corporation)
Haemonetics Announces Definitive Agreement to Acquire Attune Medical
, /PRNewswire/ -- Haemonetics Corporation ( NYSE: HAE ) , a global medical technology company focused on delivering innovative medical products and solutions to drive better patient outcomes, today announced that it has entered into a definitive agreement to acquire privately-held -based Attune ...
In Article Trend: Somewhat-Bullish
Related stocks from Healthcare sector
This website uses cookies to ensure you get the best experience on our website